Clinical Trials Browser

Phase 2 × Withdrawn × isatuximab × Clear all

NCT04802031 2022-07-07

Rapid-infusion Isatuximab in Relapsed/Refractory Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma